JPDVX
Price
$16.11
Change
-$0.14 (-0.86%)
Updated
Jun 13 closing price
Net Assets
467.49M
RLBGX
Price
$35.65
Change
-$0.31 (-0.86%)
Updated
Jun 13 closing price
Net Assets
244.39B
Interact to see
Advertisement

JPDVX vs RLBGX

Header iconJPDVX vs RLBGX Comparison
Open Charts JPDVX vs RLBGXBanner chart's image
JPMorgan Diversified L
Price$16.11
Change-$0.14 (-0.86%)
VolumeN/A
Net Assets467.49M
American Funds American Balanced R6
Price$35.65
Change-$0.31 (-0.86%)
VolumeN/A
Net Assets244.39B
JPDVX vs RLBGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JPDVX vs. RLBGX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JPDVX is a StrongBuy and RLBGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBGX has more cash in the bank: 244B vs. JPDVX (467M). JPDVX pays higher dividends than RLBGX: JPDVX (2.59) vs RLBGX (2.23). JPDVX was incepted earlier than RLBGX: JPDVX (32 years) vs RLBGX (16 years). JPDVX (0.80) is less costly to investors than RLBGX (0.25). JPDVX is a more actively managed with annual turnover of: 63.00 vs. RLBGX (44.00). RLBGX has a lower initial minimum investment than JPDVX: RLBGX (250) vs JPDVX (3000000). JPDVX (5.78) and RLBGX (5.63) have marching annual gain over last year. RLBGX return over 5 years is better than : 40.35 vs. JPDVX (13.11).
JPDVXRLBGXJPDVX / RLBGX
Total Expense Ratio0.650.25260%
Annual Report Gross Expense Ratio0.800.25320%
Fund Existence32 years16 years-
Gain YTD4.2554.59293%
Front LoadN/AN/A-
Min. Initial Investment30000002501,200,000%
Min. Initial Investment IRAN/AN/A-
Net Assets467M244B0%
Annual Yield % from dividends2.592.23116%
Returns for 1 year5.785.63103%
Returns for 3 years24.4733.7872%
Returns for 5 years13.1140.3532%
Returns for 10 years13.3660.8722%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CCCC1.680.06
+3.70%
C4 Therapeutics
PNTG27.67-0.07
-0.25%
Pennant Group (The)
UTHR283.35-2.79
-0.98%
United Therapeutics Corp
GSAT21.95-0.24
-1.08%
Globalstar Inc
KTTA0.79-0.04
-5.21%
Pasithea Therapeutics Corp